Utility of Fine Needle Aspiration Supernatant for Real-Time PCR-Based Mutation Analysis in Non-Small Cell Lung Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Personalized therapy and molecular sequencing are revolutionizing advanced non-small cell lung carcinoma (NSCLC) management.
• Fine needle aspiration (FNA) supernatants are a viable source for nucleic acid extraction in molecular testing.
• The choice of FNA rinse medium is a critical pre-analytic factor impacting molecular analysis success.

Purpose of the Study:

• To evaluate the impact of three different FNA rinse media on DNA yield and mutation detection via RT-PCR.
• To compare the performance of CytoRich Red, formalin, and bovine serum albumin (BSA) for KRAS and EGFR mutation analysis in NSCLC specimens.

Main Methods:

• A prospective study involving 31 FNA specimens collected in CytoRich Red, 10% neutral buffered formalin, or 10% BSA.
• DNA extraction using the QIAamp DNA FFPE Tissue Kit.
• Real-time PCR (RT-PCR) using QIAGEN therascreen EGFR or KRAS RGQ PCR kits.
• Comparison with direct smears or cell block/core biopsy controls.

Main Results:

• CytoRich Red yielded 11 specimens with results concordant to controls; one required repeat extraction.
• Formalin yielded 12 specimens, with 9 concordant results; several required repeat extractions, and one remained invalid.
• BSA yielded 8 specimens, with 5 concordant results; three failed PCR pre-tests despite repeat extractions.

Conclusions:

• CytoRich Red demonstrated reliable performance for RT-PCR-based mutation testing in this cohort.
• FNA supernatant is a practical alternative specimen for lung cancer molecular analysis.
• Using FNA supernatant may optimize specimen utilization and preserve cell block material.